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Phosphatidylethanolamine (PE) and phosphatidylcholine (PC) are among the most abundant 
phospholipids in biological membranes. In many eukaryotes, the CDP-ethanolamine and CDP-choline 
branches of the Kennedy pathway represent major and often essential routes for the production 
of PE and PC, with ethanolamine and choline/ethanolamine phosphotransferases (EPT and CEPT, 
respectively) catalysing the last reactions in the respective pathways. Although the site of PE and 
PC synthesis is commonly known to be the endoplasmic reticulum (ER), detailed information on the 
localization of the different phosphotransferases is lacking. In the unicellular parasite, Trypanosoma 
brucei, both branches of the Kennedy pathway are essential for cell growth in culture. We have 
previously reported that T. brucei EPT (TbEPT) catalyses the production of ether-type PE molecular 
species while T. brucei CEPT (TbCEPT) synthesizes diacyl-type PE and PC molecular species. We 
now show that the two enzymes localize to different sub-compartments of the ER. By expressing 
a series of tagged forms of the two enzymes in T. brucei parasites, in combination with sub-cellular 
fractionation and enzyme activity measurements, TbEPT was found exclusively in the perinuclear 
ER, a distinct area located close to but distinct from the nuclear membrane. In contrast, TbCEPT was 
detected in the bulk ER.
Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are the most abundant glycerophospho-
lipids in eukaryotes1,2. Besides their roles as main structural components of all cellular membranes, PC 
and PE fulfil various other functions. PC is an important source for the formation of second messengers 
and lipid mediators3,4. Disturbance of its production interferes with cell proliferation, differentiation and 
membrane movement throughout the cell1. On the other hand, PE plays essential roles in autophagy, 
cell division and protein folding, and represents a precursor for the synthesis of several protein modifi-
cations5,6. In addition, both PC and PE are intermediates in the synthesis of other glycerophospholipid 
classes7,8.
De novo formation of PE and PC in eukaryotes occurs via several pathways. PE can be synthesized 
by the CDP-ethanolamine branch of the Kennedy pathway9, decarboxylation of phosphatidylserine (PS)5 
and base exchange with PS10, while PC is formed via the CDP-choline branch of the Kennedy pathway9 
and methylation of PE11. In addition to de novo synthesis, PE and PC can be generated by acylation of 
lyso-phospholipids taken up by cells from the environment12,13.
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The Kennedy pathway plays a central role in both PE and PC synthesis. Although it is not essential for 
growth of yeast under normal conditions14, the pathway is indispensable for mammalian development15 
and survival of various unicellular eukaryotes16. In the CDP-ethanolamine branch, ethanolamine kinase 
catalyses the ATP-dependent phosphorylation of ethanolamine to ethanolamine-phosphate, which in 
turn becomes activated to CDP-ethanolamine by ethanolamine-phosphate cytidylyltransferase. In anal-
ogy, in the CDP-choline branch, choline is phosphorylated and activated to CDP-choline by choline 
kinase and choline-phosphate cytidylyltransferase, respectively. The final reactions in PE and PC for-
mation by the Kennedy pathway are catalysed by enzymes with variable substrate specificities: i) CPT 
enzymes are highly specific for the CDP-choline branch, leading to formation of PC, ii) CEPT enzymes 
show a dual specificity for CDP-choline and CDP-ethanolamine, resulting in the formation of PC and 
PE, respectively, and iii) EPT enzymes exhibit high specificity for CDP-ethanolamine, leading to PE 
formation. Although CPT enzymes (hCPT117 and ScCPT118) and CEPT enzymes (hCEPT117, AtAAPT1 
and 219 and TbCEPT20) have been identified and characterized in some cells, their specificities are poorly 
defined. hEPT121 and TbEPT20 seem to be specific for PE formation, while ScEPT118 and CrEPT22 are 
also able to synthesize PC to a lesser extent.
The localization of CPT, CEPT and EPT enzymes defines the sites of PC and PE production in a 
cell. However, only few reports have addressed this crucial question and, thus, the enzymes’ sub-cellular 
distribution has largely remained elusive. In mammalian cells, CPT1 has been localized to the Golgi, 
while CEPT1 was found in the endoplasmic reticulum (ER) and nuclear envelope23. In contrast, yeast 
CPT1 was enriched in microsomal fractions and in the Golgi24,25, whereas a GFP-tagged version of CPT1 
didn’t co-localize with any known organelle marker26. In addition, GFP-tagged yeast EPT1 revealed a 
punctate staining, showing at least partial co-localization with a Golgi marker26. More recently, immu-
nofluorescence studies in Toxoplasma gondii showed co-staining of two putative EPT enzymes with an 
ER marker27. However, the substrate specificities and products of the two enzymes have not been deter-
mined, i.e. it is unclear if they represent CEPT or EPT enzymes.
Trypanosoma brucei is the causative agent for Human African Trypanosomiasis (HAT) and nagana, 
the equivalent animal disease. These diseases are lethal if untreated and represent a major cause of pov-
erty in sub-Saharan Africa28. Unfortunately, currently available drugs can cause serious secondary effects 
and lack efficacy against certain forms of the disease, thus the identification of novel drug targets and 
development of new compounds to combat trypanosomes represent a major focus of the research com-
munity29–31. Two replicative stages of T. brucei are studied most frequently, the procyclic form of the 
insect midgut and the long slender bloodstream form of the mammalian host. Both parasite life stages 
can be grown easily in culture. T. brucei has also been used as valuable model eukaryote to study various 
biological processes, including phospholipid biosynthesis6,32. The lipid composition of T. brucei is similar 
to that of other eukaryotes, with PC (45–60%) and PE (10–20%) representing the major glycerophospho-
lipid classes33,34. Interestingly, and in contrast to many other eukaryotes, T. brucei glycerophospholipids 
contain very high amounts of ether-type phospholipid subclasses35,36, in particular PE, which consists of 
> 80% and > 60% of ether-type molecular species in procyclic and bloodstream forms, respectively20,35,36. 
Although T. brucei parasites can acquire lipids from the environment, de novo phospholipid synthesis 
is essential for parasite survival of both bloodstream and procyclic forms33,34. The Kennedy pathway for 
PE and PC synthesis has been studied in detail in T. brucei. The enzymes of the CDP-ethanolamine and 
CDP-choline branches are expressed in both bloodstream and procyclic forms and have been studied 
experimentally20,37,38. Although other biosynthetic routes for PE synthesis are active in T. brucei, trypa-
nosome growth depends on a functional Kennedy pathway for both PE and PC formation, making the 
individual enzymes of the pathway interesting potential drug targets to inhibit parasite proliferation16.
Our previous study in T. brucei procyclic forms using RNA interference to separately knock down 
EPT and CEPT was the first to show in a eukaryote that TbEPT is responsible for the synthesis of 
ether-type PE molecular species whereas TbCEPT mediates the formation of diacyl-type PE and all PC 
molecular species (Fig. 1)20. Interestingly, while the two enzymes use the same hydrophilic substrate, i.e. 
CDP-ethanolamine, for PE production, the hydrophobic substrates are different. Synthesis of ether-type 
molecular species by EPT requires alk-1-enyl-acylglycerol or alkyl-acylglycerol (both referred to as AAG 
in the present study), while diacyl-type molecular species formation by CEPT requires diacylglycerol 
(DAG) as substrate. In general, the synthesis of the different hydrophobic substrates is thought to occur 
in different compartments in eukaryotes. While the formation of AAG seems restricted to peroxisomes39, 
or similar specialized compartments in other cells such as glycosomes in T. brucei40,41, DAG can be 
produced at several locations. The goal of the present work was, using T. brucei as eukaryotic model 
organism, to study the sub-cellular localization of EPT and CEPT, which catalyse the last step of the 
two branches of the Kennedy pathway, in a single cell. By expressing several differently tagged forms of 
TbEPT and TbCEPT and their subsequent analysis using immunofluorescence, sub-cellular fractionation 
and enzyme activity measurements, we found that TbEPT localizes exclusively to perinuclear membranes 
while TbCEPT shows a dual distribution between the ER and the perinuclear region. These findings have 
important implications on the availability of the substrates for PE and PC synthesis, AAG and DAG, in 
the respective compartments.
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Results and Discussion
According to their in vitro and in vivo substrate specificities, EPT/CEPT and CEPT/CPT enzymes cat-
alyse the last step in the two branches of the Kennedy pathway, leading to the formation of the most 
abundant eukaryotic glycerophospholipid classes PE and PC, respectively. Although scattered data about 
the sub-cellular localization of CPT, CEPT and EPT in mammalian cells, yeast and Toxoplasma is avail-
able23–27, the results are conflicting and provide no clear information on the site(s) of de novo synthesis 
of PC and PE. In particular, a detailed study to localize these enzymes in a single cell is lacking. In 
T. brucei parasites, PE and PC synthesis by the Kennedy pathway is essential and the substrate specifici-
ties of TbEPT and TbCEPT have been characterized using RNAi cell lines to down-regulate the enzymes 
individually20,38. In the present study, we have analysed the localization of TbCEPT and TbEPT by immu-
nofluorescence microscopy of differently tagged forms of the enzymes, and by sub-cellular fractionation 
and enzyme activity measurements.
Localization of tagged forms of TbEPT and TbCEPT. Based on its previously reported specificity 
for the synthesis of ether-type PE molecular species in T. brucei procyclic forms20, we expected TbEPT 
to localize in glycosomes, which are the site of ether-type (alk-1-enyl-acylglycerol and alkyl-acylglycerol) 
precursor synthesis40. In contrast, we found that expression of a C-terminally 3xHA-tagged version 
of TbEPT (TbEPT-3xHA) showed a perinuclear staining, but no co-localization with the glycosomal 
marker aldolase (Fig.  2A, top panels). A similar staining was also observed in parasites expressing 
an N-terminally 2xcmyc-tagged TbEPT or an in situ C-terminally 3xHA-tagged form of the enzyme 
(Fig. 2A, middle and bottom panels, respectively). Remarkably, we observed little or no co-localization 
of TbEPT with the ER marker BiP. The exclusive perinuclear localization of TbEPT was independent of 
the position of the tag (N- or C-terminal), the nature of the tag (HA, cmyc or GFP (see below)) or the 
method used to express the tagged protein (inducible versus stable expression), and was seen in > 95% 
of cells, indicating that the results likely reflect the genuine localization of TbEPT. Together, these results 
indicate that TbEPT is not localized in the bulk ER, i.e. the site of PE formation in other eukaryotes, but 
in a sub-compartment in close proximity to the nuclear membrane.
In addition, we analysed the sub-cellular localization of TbCEPT in T. brucei procyclic forms by 
expressing an N-terminally 3xcmyc-tagged version of the enzyme. The results show an essentially com-
plete co-localization of TbCEPT with the ER marker BiP (Fig. 2B).
Because of the close apposition of the nuclear membrane and the region of the ER closest to the 
nuclear membrane, the unique perinuclear staining pattern of TbEPT was further investigated. To dis-
tinguish between nuclear and ER membranes, procyclic forms expressing TbEPT and TbCEPT whose 
C-termini were fused to GFP were co-stained with an antibody (MAb414) directed against nuclear pore 
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Figure 1. PE and PC synthesis via the Kennedy pathway in Trypanosoma brucei. TbEPT synthesizes 
exclusively ether-type PE using AAG as substrate, while TbCEPT synthesizes both diacyl-type PE and PC 
using DAG substrate. The T. brucei genome lacks a gene encoding CPT. E/CK, ethanolamine/choline kinase; 
E/CCT, ethanolamine/choline cytidylyltransferase, EPT, ethanolamine phosphotransferase; CEPT, choline/
ethanolamine phosphotransferase, AAG, alk-1-enyl-acylglycerol/alkyl-acylglycerol; DAG, diacylglycerol; 
CMP, cytidine monophosphate.
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complex proteins. TbEPT-GFP showed the above mentioned ring-like distribution around the nucleus 
(Fig. 3A; compare with Fig. 2A). However, although staining with MAb414 revealed a similar ring-like 
staining pattern, little co-localization with TbEPT-GFP was observed (Fig. 3A). In addition, in agreement 
with the staining of 3xcmyc-TbCEPT (Fig. 2B), TbCEPT-GFP showed staining of the bulk ER. Again, as 
for TbEPT-GFP, little co-localization was observed between TbCEPT-GFP and MAb414.
Localization of TbEPT and TbCEPT in a single cell. To localize both TbEPT and TbCEPT in a 
single parasite, TbEPT-GFP and 3xcmyc-TbCEPT were co-expressed and analysed by (immuno)fluores-
cence microscopy (Fig. 3B). The results show that the two enzymes co-localize in the ER region proximal 
to the nucleus, however, while TbEPT is confined to the perinuclear region only, TbCEPT is distributed 
throughout the ER network. Together, our results demonstrate that TbEPT is located exclusively in an 
ER sub-domain in close proximity but distinct from the nuclear membrane. In contrast, TbCEPT reveals 
a staining pattern typical for bulk ER, although a sub-fraction co-localizes with TbEPT.
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Figure 2. Sub-cellular localization of TbEPT and TbCEPT by immunofluorescence microscopy. T. brucei 
procyclic forms expressing tagged versions of (A) TbEPT or (B) TbCEPT (with the types and positions of 
the tags indicated in the left margin) were immunostained with antibodies against HA or cmyc, together 
with antibodies against aldolase (glycosomal marker) or BiP (luminal ER marker), in combination with 
the respective fluorescence-conjugated secondary goat anti-mouse and anti-rabbit antibodies. DNA in the 
composite pictures was stained with DAPI. DIC, differential interference contrast.
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Sub-cellular fractionation and enzyme activity measurements. The sub-cellular localization of 
TbEPT and TbCEPT was also investigated using cell fractionation of different trypanosome cell lines. To 
compare the sub-cellular distribution of the tagged enzymes with endogenous TbCEPT activity, a mixed 
culture of T. brucei procyclic forms expressing either TbEPT-3xHA or 3xcmyc-TbCEPT was fractionated 
by differential centrifugation (Fig.  4A). Subsequently, in each sub-cellular fraction the presence of the 
tagged enzymes was analysed by SDS-PAGE and immunoblotting (Fig. 4B) and the enzymatic activity 
DIC TbEPT-GFP 3xcmyc-TbCEPT Composite
TbC/EPT-GFPDIC MAb414 Composite
TbEPT
TbCEPT
A
B
Figure 3. Localization of tagged forms of TbEPT and TbCEPT in the same cell. Panel (A) GFP-tagged 
TbEPT (top panels) and TbCEPT (bottom panels) were transiently expressed in T. brucei procyclic forms 
and co-stained with MAb414, a nuclear pore complex marker. Panel (B) GFP-tagged TbEPT was transiently 
expressed in procyclic forms stably expressing 3xcmyc-TbCEPT and cells were immunostained with anti-
cmyc antibody and fluorescence-conjugated goat anti-mouse antibody. DNA in the composite pictures was 
stained with DAPI. DIC, differential interference contrast.
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Figure 4. Sub-cellular distribution of TbCEPT and TbEPT protein and enzyme activity. Panel (A) 
Preparation of sub-cellular fractions. Procyclic trypanosomes were broken up by N2 cavitation and 
fractionated by differential centrifugation as indicated. Whole cell lysate (WC), cytosol and microsomes 
(CM), membranes and organelles (MO), soluble cytosol (Cyto) and microsomal (Micros) fractions were 
subsequently analysed for the presence of tagged TbCEPT and TbEPT and enzyme activity. Panel (B) SDS-
PAGE and Western blot analysis of sub-cellular fractions from a mixed culture of trypanosomes expressing 
3xcmyc-CEPT or EPT-3xHA. Proteins were detected using antibodies against HA, cmyc, BiP (as ER marker), 
mtHSP70 (as mitochondrial marker), MAb414 (as nuclear envelope marker) and aldolase (as glycosomal 
marker). Panel (C) TbCEPT activity in sub-cellular fractions as determined using [14C]CDP-choline as 
substrate and TLC to separate the products. All fractions contained identical amounts of protein. [14C]PC 
formation was quantified by scanning the TLC plates using a radioisotope detector. The values represent 
means ± standard deviations from 3 experiments. The asterisk indicates a significant difference in TbCEPT 
activity between the microsomal fraction (Micros) and all other fractions (p < 0.05, Student’s t-test). Panel 
(D) [3H]PC and [3H]PE formation in TbCEPT RNAi trypanosomes. Control (-Tet) and tetracycline-
induced (+ Tet) cells, resulting in depletion of TbCEPT, were incubated in presence of [3H]choline or [3H]
ethanolamine and formation of [3H]PC and [3H]PE, respectively, was detected after lipid extraction and TLC 
analysis using a radioisotope detector. Panel (E) TbEPT activity in sub-cellular fractions of TbCEPT-depleted 
trypanosomes as determined using [14C]CDP-ethanolamine as substrate and TLC to separate the products. 
All fractions contained identical amounts of protein. [14C]PE formation was quantified by scanning the TLC 
plates using a radioisotope detector. The values represent means ± standard deviations from 3 experiments. 
The asterisks indicate a significant difference in TbEPT activity between the microsomal (MO) fraction, or 
the membranes and organelles (Micros) fraction, and the WC, CM and Cyto fractions (p < 0.05, Student’s 
t-test). WC, whole cells; CM, cytosol and microsomes; MO, membranes and organelles; Cyto, soluble 
cytosol; Micros, microsomes.
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of TbCEPT was determined (Fig. 4C). The results show the highest enrichment of 3xcmyc-TbCEPT in 
the microsomal fraction, while TbEPT-3xHA was enriched the most in the membranes and organelles 
fraction (Fig. 4B). These findings support the immunofluorescence results showing that the two tagged 
enzymes localize differently in T. brucei. The distribution of marker proteins for mitochondria (mtHSP70), 
ER (BiP) and glycosomes (aldolase) in the different fractions confirms previous results42 and shows 
that the microsomal fraction is depleted of mitochondrial and nuclear (MAb414) membranes, while it 
contains the markers for ER and glycosomes (Fig.  4B). Determination of TbCEPT activity using [14C]
CDP-choline as substrate in the fractions after differential centrifugation showed highest [14C]PC forma-
tion in the microsomal fraction (Fig. 4C). This result is in line with the enrichment of 3xcmyc-TbCEPT 
in the same fraction (Fig. 4B). Since TbCEPT activity was identical in parasites before and after induction 
of 3xcmyc-TbCEPT expression (results not shown), indicating that the tagged enzyme doesn’t contribute 
significantly to endogenous TbCEPT activity or that 3xcmyc-TbCEPT while correctly localized is not 
active, the measured in vitro activity represents endogenous TbCEPT activity.
To determine the sub-cellular distribution of endogenous TbEPT activity, an RNAi cell line allowing 
down-regulation of TbCEPT expression20 was used for the following reason. TbCEPT shows dual sub-
strate activity, i.e. it not only catalyses the production of PC but also PE20 and, thus, its activity contributes 
to [14C]PE formation when using [14C]CDP-ethanolamine as substrate. Therefore, to allow determination 
of TbEPT activity in the absence of TbCEPT, TbCEPT mRNA was silenced using tetracycline-inducible 
RNAi. Absence of TbCEPT activity was confirmed by the inability of TbCEPT-depleted parasites to form 
[3H]PC using [3H]choline as substrate (Fig. 4D, upper panels). In contrast, TbEPT-mediated formation 
of [3H]PE using [3H]ethanolamine as substrate was unchanged in TbCEPT-depleted parasites (Fig. 4D, 
lower panels). These results are in line with previous data20. Analysis of [14C]PE formation in the frac-
tions after differential centrifugation from TbCEPT-depleted parasites revealed highest TbEPT activity 
in the membranes and organelles and microsomal fractions (Fig. 4E). The result is in good agreement 
with the enrichment of TbEPT-3xHA in these fractions (Fig. 4B).
Further fractionation of the membranes and organelles fraction, containing 3xcmyc-TbCEPT and 
TbEPT-3xHA, using a linear 18–50% Nycodenz gradient (Fig. 5A) again revealed a different distribution 
pattern for the two enzymes (Fig. 5B). TbEPT-3xHA co-fractionated most closely with BiP and mtHSP70 
at the top of the gradient, while 3xcmyc-TbCEPT showed a dual enrichment in the upper (fractions 
1–3) and middle fractions (fractions 11–13). While the distribution of 3xcmyc-CEPT partly overlapped 
with MAb14 and aldolase, the fractions showing the highest enrichment of the respective enzymes are 
clearly different. These results are consistent with the immunofluorescence pictures showing that TbEPT 
and TbCEPT are localized differently and are not enriched in glycosomal or nuclear membranes (Figs 2 
and 3).
Conclusions
In T. brucei parasites, TbEPT and TbCEPT catalyse the last step in the CDP-ethanolamine and 
CDP-choline branches of the Kennedy pathway and, thus, determine the site(s) of synthesis of the two 
major glycerophospholipid classes PE and PC, respectively. Both pathways are essential for growth 
of parasites in culture20,38. Our work using immunofluorescence microscopy and immunoblotting to 
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Figure 5. Fractionation of TbCEPT and TbEPT by gradient centrifugation. Panel (A) The membranes 
and organelles fraction, obtained after breaking up the cells followed by a centrifugation step, was further 
separated using a linear Nycodenz gradient. Fractions collected from the top of the gradient were then 
analysed for the presence of tagged TbCEPT and TbEPT. Panel (B) SDS-PAGE and Western blot analysis 
of odd-numbered fractions from a mixed culture of trypanosomes expressing 3xcmyc-CEPT or EPT-3xHA. 
Proteins were detected using antibodies against HA, cmyc, BiP (as ER marker), mtHSP70 (as mitochondrial 
marker), MAb414 (as nuclear envelope marker) and aldolase (as glycosomal marker).
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localize differently tagged forms of TbEPT and TbCEPT, in combination with sub-cellular fractionation 
and activity measurements to determine the distribution of the endogenous enzymes, showed that both 
TbEPT and TbCEPT are present in the ER. However, TbEPT is confined to the perinuclear region of the 
compartment while TbCEPT is distributed throughout the entire ER network. The reactions catalysed 
by TbEPT and TbCEPT, both of which are predicted to have multiple transmembrane domains and 
thus are tightly membrane-bound, combine water-soluble CDP-activated precursors with hydrophobic 
substrates, i.e. DAG and/or AAG. Although the site(s) of DAG production in trypanosomes has not 
been studied, it is generally believed that DAG is available in all membranes. In contrast, production of 
AAG in T. brucei has been localized in glycosomes40. Our observation that TbEPT is localized exclu-
sively in the perinuclear ER implies that the hydrophobic substrate of the reaction, AAG, is available 
in this sub-compartment, or in very close proximity. At present, it is not known if a sub-population of 
glycosomes associates with the perinuclear ER or if AAG can be trafficked from glycosomes to other 
organelles. Mechanisms to transfer AAG from glycosomes to the perinuclear ER may involve protein- or 
vesicle-mediated transport, or direct membrane contact sites.
EPT and CEPT/CPT enzymes are present in essentially all eukaryotic cells. It will be interesting to 
study if the two enzymes show a similar intracellular distribution in other unicellular organisms, or 
mammalian cells.
Methods
Unless otherwise stated, all reagents were of analytical grade and purchased from Sigma-Aldrich (Buchs, 
Switzerland) or Merck (Darmstadt, Germany). Restriction enzymes were obtained from Fermentas 
(St. Leon-Rot, Germany) and antibiotics from Sigma-Aldrich, Invivogen (Nunningen, Switzerland) 
or Invitrogen (Basel, Switzerland). [14C]CDP-choline (methyl-[14C]) and [14C]CDP-ethanolamine 
(ethanolamine-1,2-[14C]) (both 0.1 mCi/ml, 55 mCi/mmol), and [3H]choline and [3H]ethanolamine (both 
1 mCi/ml, 60 mCi/mmol) were purchased from American Radiolabeled Chemicals (St. Louis, USA).
Trypanosomes and culture conditions. T. brucei procyclic form strain 427 was cultured at 27 °C 
in SDM-7943 containing 5% heat-inactivated fetal bovine serum (Invitrogen). T. brucei procyclic form 
strain 29–13 co-expressing a T7 polymerase and a tetracycline repressor44 (obtained from Paul Englund, 
Baltimore, MD) was cultured at 27 °C in SDM-79 containing 10% heat-inactivated fetal bovine serum, 
25 μ g/mL hygromycin, and 15 μ g/mL G418.
Generation of tagged TbCEPT and TbEPT. To generate C-terminally GFP (green fluorescent 
protein)-tagged forms of TbEPT (Tb927.10.13290) and TbCEPT (Tb927.10.8900), the correspond-
ing open reading frames were amplified by PCR using primers EPT_GFP_Fw GCCCAAGCTTAT 
GGGAGTAGTAGACTTACTCACTTCT and EPT_GFP_Rv GCCGCTCGAGTCCACTTTCCTTACGG 
AGCCCT, and CEPT_GFP_Fw GCCCAAGCTTATGAACGCGCCTCACAGAACTC and CEPT_GFP_
Rv GCCGCTCGAGTCCCACTTCGTGTTGGAGTCATG (restriction sites underlined), respectively. The 
products were ligated into HindIII- and XhoI-digested plasmid pG-EGFPΔ LII b45, resulting in plas-
mids pLFeptGFP and pLFceptGFP. To generate C-terminally 3xHA (hemagglutinin)-tagged TbEPT and 
N-terminally 3xcmyc-tagged TbCEPT, the corresponding open reading frames were amplified by PCR using 
primers EPT_GFP_Fw and EPT_HA_Rv CGCTCTAGACTCCACTTTCCTTACGGAGCC, and CEPT_
cmyc_Fw GCCCAAGCTTAACGCGCCTCACAGAGCTC and CEPT_cmyc_Rv GCGGGATCCCTACT 
CCCACTTCGTGTTGGCG, respectively. The products were ligated into two vectors: i) HindIII- and 
XhoI-digested plasmid pAG3020-346, resulting in plasmid pLFeptHA, and ii) HindIII- and BamHI-digested 
plasmid pJM247, resulting in plasmid pLFceptCMYC, respectively. Generation of N-terminally 2xcmyc 
tagged TbEPT was done by amplification of TbEPT open reading frame using primer EPT_cmyc_
Fw containing 2xcmyc CCCGAAGCTTATGGAGCAGAAGCTCATTTCTGAGGAGGACCTTGAGC 
AGAAGCTCATTTCTGAGGAGGACCTTCTCGAGGGAGTAGTAGACTTACTCACTTCTACGCG 
(2xcmyc sequence in italic) and primer EPT_cmyc_Rv CGCGGATCCTCACTCCACTTTCCTTAC 
GGAGCCCT. The product was ligated into HindIII- and BamHI-digested plasmid pALC14 (derivative of 
pLew10044) resulting in plasmid pLFeptCMYC. To generate C-terminal in situ tagged TbEPT, a one-step 
PCR strategy with the vector pMOTag3H was followed as described previously48.
Stable and transient transfection of trypanosomes. Trypanosomes were harvested at mid-log 
phase, washed once in phosphate-buffered saline (PBS; 137 mM sodium chloride, 2.7 mM potassium 
chloride, 10 mM disodium phosphate, 2 mM monopotassium phosphate, pH 7.4) and resuspended in 
100 μ l TbBSF buffer (90 mM sodium phosphate, 5 mM potassium chloride, 0.15 mM calcium chloride, 
50 mM HEPES, pH 7.3)49 previously mixed with 10 μ g of plasmid or 4 μ g of purified PCR product (in situ 
tag). Electroporation was performed in 100 μ l nucleocuvettes using Lonza 4D Nucleofector System (pulse 
code FI-115, “Primary Cell P3” solution). GFP constructs were expressed transiently (circular plasmids 
were transfected into 427 strain and slides were prepared 18–24 hours after transfection) whereas HA and 
cmyc constructs were stably transfected into 29–13 strain (plasmids were linearized with NotI prior to 
transfection). Clones were obtained by limited dilution and selected in the presence of the corresponding 
antibiotic, 2 μ g/ml puromycin for HA and cmyc constructs, or 15 μ g/ml G418 for the in situ construct. 
Proper integration of the constructs was confirmed by PCR using primers binding upstream of the 
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recombination site and downstream of the inserted gene. Expression of HA- or cmyc-tagged proteins 
was induced by addition of 1 μ g/ml tetracycline to the culture medium.
Fluorescence microscopy. Trypanosomes were collected and washed once in cold PBS before being 
allowed to adhere onto microscopy slides (Thermo Scientific) for 10 min. Cells were fixed with 4% par-
aformaldehyde, washed once with cold PBS and permeabilized with 0.2% (w/v) Triton X-100 in PBS. 
Blocking was performed with 2% bovine serum albumin in PBS (blocking solution) for 30 min, fol-
lowed by 45 min incubation of first antibody diluted in blocking solution. The following antibodies were 
used: mouse monoclonal α -cmyc 9E10 (Santa Cruz Biotechnology; diluted 1:200), mouse monoclo-
nal α -HA.11 16B12 (Covance, diluted 1:250), rabbit α -BiP (a kind gift of James D. Bangs, University 
of Buffalo, Buffalo, NY; diluted 1:2500), rabbit α -aldolase (a kind gift of Paul Michels, University of 
Edinburgh, Edinburgh, Scotland; diluted 1:5000), and mouse α -nuclear pore complex proteins (MAb414, 
Covance; diluted 1:5000). After washing, the corresponding secondary antibodies goat anti-mouse and 
anti-rabbit AlexaFluor 594 and 488 (Invitrogen; diluted 1:800) in blocking solution were added for 45 min. 
For the preparation of GFP-expressing cells, slides were kept protected from light during the whole pro-
cedure. After washing, cells were mounted with Vectashield containing 4′ ,6-diamidino-2-phenylindole 
(DAPI, Vector Laboratories). Fluorescence microscopy was performed with a Leica DMI6000 B inverted 
microscope and pictures were acquired, processed and 3D-deconvolved with LAS X software (Leica 
Microsystems CMS GmbH).
Cell fractionation. Following a previously published procedure50, parasites were fractionated into 
a crude microsomes and a membranes and organelles fraction, the latter of which was subsequently 
fractionated using a Nycodenz gradient. Briefly, 2–4 × 1010 cells were harvested by centrifugation and 
subjected to nitrogen cavitation at isotonic conditions. Membranes and organelles (containing most 
organelles) were separated from cytosol and microsomes (crude microsomes) by differential sedimen-
tation. The membranes and organelles fraction was subjected to DNase treatment, resuspended in 80% 
Nycodenz, loaded underneath a 18–50% (w/v) linear Nycodenz gradient using a syringe and centrifuged 
for 45 min in a SW28 rotor at 27000 rpm at 4 °C. Fractions (20 × 2 ml) were collected from the top of the 
gradient. The crude microsomal fraction was diluted 1:4 in HKM buffer (50 mM HEPES, 25 mM KCl; 
5 mM MgCl2·6 H2O) and a clearing spin was carried out (30 min at 4 °C at 30000 × g in a SS34 rotor) to 
eliminate residual mitochondrial vesicles. Microsomes were collected from this cleared supernatant by 
ultracentrifugation (2 h at 4 °C at 100000 × g in a SW28 rotor). The microsomal fraction has previously 
been called crude ER fraction42.
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. Protein concen-
trations were determined using a BCA Protein Assay Kit (Pierce). Protein (10 μ g) from each fraction was 
diluted in SDS sample buffer, separated by SDS-PAGE using 12% polyacrylamide gels under reducing 
conditions51, and transferred onto nitrocellulose membranes (Thermo Scientific) by semi-dry blotting. 
After blocking in TBS buffer (10 mM Tris-HCl pH 7.5, 144 mM NaCl) containing 5% (w/v) bovine serum 
albumin (BSA), membranes were exposed to the following primary antibodies diluted in TBST (10 mM 
Tris-HCl pH 7.5, 144 mM NaCl, 0.05% (w/v) Tween20) containing 2% (w/v) BSA: mouse monoclo-
nal α -cmyc 9E10 (1:1000), mouse monoclonal α -HA.11 16B12 (1:1000), rabbit α -BiP (1:25000), rabbit 
α -aldolase (1:1000), mouse α -mtHSP70 (a gift of Paul E. Englund, Baltimore, MD; diluted 1:1000), and 
mouse α -nuclear pore complex proteins (MAb414; diluted 1:500). Corresponding secondary antibodies 
were used at a dilution of 1:20000 (DyLight conjugate, Pierce). Detection of fluorescent antibodies was 
done using the Odyssey Imaging System (LI-COR).
C/EPT activity assays and lipid analysis. Activity assays were performed using 80 μ g of protein in 
100 μ l of HKM buffer.
CEPT assay. 80 μ g of protein from sub-cellular fractions were incubated for 50 min at 27 °C in 100 μ l assay 
buffer (50 mM Tris pH 8.0, 10 mM MgCl2·6 H2O, 0.005% (w/v) Tween20), supplemented with 5 nmoles 
CDP-choline, 0.9 nmoles [14C]CDP-choline, 2.5 nmoles diacylglycerol and 2.5 nmoles alkyl-acylglycerol. 
After incubation, lipids were extracted twice by addition of 250 μ l 1-butanol, centrifugation and isolation 
of the organic phase.
EPT assay. The assay was performed as described for CEPT, with CDP-ethanolamine and [14C]
CDP-ethanolamine as substrates instead of CDP-choline and [14C]-labeled CDP-choline.
Thin layer chromatography (TLC). Lipid classes were separated on silica gel 60 plates (Merck) by 
one-dimensional TLC using a solvent system composed of chloroform: methanol: acetic acid: water 
(25:15:4:2, by vol.). Lipid standards were run on each plate alongside the samples to be analysed. 
Radioactive lipids were detected by scanning the air-dried plate with a radioisotope detector (Berthold 
Technologies) and quantified using the Rita Star software provided by the manufacturer.
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PE and PC synthesis in TbCEPT RNAi parasites. Metabolic labeling of trypanosomes with [3H]
choline or [3H]ethanolamine was done as described previously20. Briefly, 2.5 μ Ci/ml [3H]choline or 
0.5 μ Ci/ml [3H]ethanolamine was added to 4 × 107 trypanosomes in culture medium and incubated for 
2 h at 27 °C. Cells were harvested, washed once in TBS buffer and lipids were extracted20. [3H]-labeled 
PC and PE were analysed by TLC as described above.
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